Sachetta Eric purchased $226K of SRTS
Sachetta Eric purchased 64,841 shares of Sensus Healthcare, Inc. (SRTS) at an average of $3.48 ($3.44–$3.54, $0.23M total) across 2 trades over 2026-08-28 to 2026-08-31.
How this was made
The 30-second read
Why it matters
The modest purchase adds a small amount of insider confidence but is unlikely to move the stock significantly.
Market read
A routine insider purchase with limited trading relevance.
What to watch
Potential upcoming clinical data or regulatory events not disclosed in the filing could give the purchase more meaning.
Background
SEC Form 4 filing reporting an insider purchase by a director of Sensus Healthcare.
Ticker impact
Director Eric Sachetta purchased 64,841 shares of Sensus Healthcare for $225,616, increasing his stake to 294,784 shares.
Limited short‑term impact; may provide slight upside bias if market perceives insider confidence.
The transaction size (~$226K) is small relative to the company's market cap, so price reaction is likely muted.
Market effects
Minimal; reflects typical insider activity in the healthcare sector.
None; the filing is company‑specific.
Low; does not affect broader market trends.
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a strong bullish signal.
Key entities
- CompanySensus Healthcare, Inc.
Biopharmaceutical company listed on Nasdaq under ticker SRTS.
- InsiderEric Sachetta
Director of Sensus Healthcare who made the purchase.